Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.
(2)Dr. Rafik Karaman Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Reviewers:
(1) Rufai Safianu, University of health and allied sciences, Ghana.
(2) Mahmood J. Jawad, Al Zahrawi University College, Iraq.
Additional Reviewers:
(1) Abiyie Zeleke Alem, Debre Markos university, Ethiopia.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.5/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Rufai Safianu, Ghana) | File 1 | File 2
Stage 2 | Peer review report_2 (Mahmood J. Jawad, Iraq) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA